Lupin Steps Up Fight With Mylan Over Generic Antara
Lupin Atlantis first sued Canonsburg, Pa.-based Mylan in March, alleging the generic-drug maker had infringed U.S. Patent Numbers 7,101,574 and 7,863,331. The patents, issued in September 2006 and this January, cover the composition and preparation of the drug, and methods of treatment using the drug, respectively.
The more recent suit also names Ethypharm...
To view the full article, register now.